Sal HaTziyud
The Israeli Health Services Basket — the annually updated list of medications, treatments, technologies, and services that Israel's four health funds are legally required to provide to all citizens under the National Health Insurance Law.
Sal HaTziyud (סל שירותי הבריאות, literally "Health Services Basket," also rendered Sal Habriut or the Health Basket) is the annually updated statutory list of medications, medical technologies, treatments, and health services that Israel's four health funds — Clalit, Maccabi, Leumit, and Meuchedet — are legally required to provide to all Israeli residents under the 1994 National Health Insurance Law (Hok Bituah Briut Mamlachti).
Each year, the Israeli government allocates a budget increment for new basket additions. A public advisory committee — chaired by the Director General of the Ministry of Health — reviews applications from pharmaceutical companies, medical-device manufacturers, patient-advocacy organizations, and clinical experts. The committee ranks technologies by clinical benefit, cost-effectiveness, disease burden, and budget impact, then recommends additions within the allocated budget. The final list is approved by the Minister of Health and published in an official gazette.
For pharmaceutical and medical-device companies, basket inclusion is the single most consequential commercial event in the Israeli market. A drug inside the basket is provided to all 9.8 million Israeli residents through their health fund at no or minimal co-pay. A drug outside the basket must be purchased privately or through supplementary insurance — dramatically limiting its addressable market. The basket review process is therefore the central pricing and access negotiation for every multinational pharma company operating in Israel.
The basket mechanism is administered through the Tofes 17 regulatory process, which governs marketing authorization, pricing, and reimbursement classification.
See also: Sal HaTziyud (Health Services Basket) — full Olam article